DEA Will Approve Cannabis Rescheduling in 2024, Sklamberg Predicts
Life Sciences & Healthcare Regulatory partner Howard Sklamberg was recently featured in the MJBizDaily article, “DEA likely to OK marijuana rescheduling, but election and lawsuits could get in the way.” The article discusses the federal evaluation of the U.S. Department of Health and Human Services’ (HHS) recommendation to move cannabis from Schedule I to Schedule III, which was issued in August of this year.
The evaluation sits with the U.S. Drug Enforcement Administration, which Sklamberg thinks will likely sign off on HHS’s recommendation and issue a proposed rule change. “I don’t think that will take terribly long,” Sklamberg predicted. “They’ll want to have the final rule done certainly by 2024 – and probably not too late in 2024, given the political cycle.”
